[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Theravance Bio Ord (TBPH)

Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 853,202
  • Shares Outstanding, K 51,553
  • Annual Sales, $ 107,460 K
  • Annual Income, $ 105,900 K
  • EBIT $ 1 M
  • EBITDA $ 0 M
  • 60-Month Beta 0.19
  • Price/Sales 7.80
  • Price/Cash Flow N/A
  • Price/Book 2.88

Options Overview Details

View History
  • Implied Volatility 43.85% (-6.35%)
  • Historical Volatility 20.64%
  • IV Percentile 1%
  • IV Rank 4.35%
  • IV High 303.44% on 02/20/26
  • IV Low 32.03% on 09/03/25
  • Expected Move (DTE 28) 0.26 (1.56%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 15
  • Put/Call OI Ratio 12.42
  • Today's Open Interest 7,983
  • Open Int (30-Day) 8,092
  • Expected Range 16.09 to 16.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.14
  • Number of Estimates 2
  • High Estimate $0.19
  • Low Estimate $0.08
  • Prior Year $1.08
  • Growth Rate Est. (year over year) -87.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.01 +2.06%
on 05/19/26
17.17 -4.83%
on 05/05/26
-0.28 (-1.68%)
since 04/21/26
3-Month
13.08 +24.92%
on 03/03/26
19.84 -17.66%
on 02/23/26
-3.32 (-16.89%)
since 02/20/26
52-Week
9.10 +79.56%
on 05/29/25
21.03 -22.30%
on 01/22/26
+6.93 (+73.65%)
since 05/21/25

Most Recent Stories

More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH

NEW YORK , May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Theravance Biopharma, Inc. ("Theravance" or the "Company") (NASDAQ: TBPH). Such investors are...

TBPH : 16.34 (-1.27%)
Theravance Bio: Q1 Earnings Snapshot

Theravance Bio: Q1 Earnings Snapshot

TBPH : 16.34 (-1.27%)
Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update

DUBLIN , May 7, 2026 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the first quarter of...

TBPH : 16.34 (-1.27%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH

NEW YORK , April 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Theravance Biopharma, Inc. ("Theravance" or the "Company") (NASDAQ: TBPH).  Such investors...

TBPH : 16.34 (-1.27%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH

NEW YORK , April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Theravance Biopharma, Inc. ("Theravance" or the "Company") (NASDAQ: TBPH). Such investors...

TBPH : 16.34 (-1.27%)
TBPH: Reported $22M in Operating Expenses While Advancing Trial Enrollment -- LEVI & KORSINSKY, LLP Investigates

Theravance Biopharma Told Investors R&D Costs Were Declining Following Completion of CYPRESS Enrollment

TBPH : 16.34 (-1.27%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH

NEW YORK , April 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Theravance Biopharma, Inc. ("Theravance" or the "Company") (NASDAQ: TBPH).  Such investors...

TBPH : 16.34 (-1.27%)
TBPH Investors Have Opportunity to Join Theravance Biopharma, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Theravance Biopharma, Inc. (“Theravance” or “the Company”)...

TBPH : 16.34 (-1.27%)
TBPH: Reported $22M in Operating Expenses While Advancing Trial Enrollment -- LEVI & KORSINSKY, LLP Investigates

Theravance Biopharma Told Investors R&D Costs Were Declining Following Completion of CYPRESS Enrollment

TBPH : 16.34 (-1.27%)
TBPH: Reported $22M in Operating Expenses While Advancing Trial Enrollment -- LEVI & KORSINSKY, LLP Investigates

Theravance Biopharma Told Investors R&D Costs Were Declining Following Completion of CYPRESS Enrollment

TBPH : 16.34 (-1.27%)

Business Summary

Theravance Biopharma is a biopharmaceutical company primarily focused on discovering, developing and commercializing respiratory medicines. The company was formed following the split of the erstwhile Theravance into two listed companies in June 2014 - Innoviva, Inc. (then Theravance, Inc.) and Theravance.'...

See More

Key Turning Points

3rd Resistance Point 16.83
2nd Resistance Point 16.71
1st Resistance Point 16.53
Last Price 16.34
1st Support Level 16.23
2nd Support Level 16.11
3rd Support Level 15.93

See More

52-Week High 21.03
Fibonacci 61.8% 16.47
Last Price 16.34
Fibonacci 50% 15.07
Fibonacci 38.2% 13.66
52-Week Low 9.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.